Detalhe da pesquisa
1.
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
J Urol
; 207(4): 779-788, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34915741
2.
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.
Lancet Oncol
; 21(6): 776-785, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32631491
4.
Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
Urology
; 114: 60-65, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307733
5.
A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer.
Urol Oncol
; 35(2): 39.e1-39.e7, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341495